Cleveland Cord Blood Center Receives FDA Biologics License for Stem Cell Product

The Cleveland Cord Blood Center receives a biologics license from the U.S. Food and Drug Administration for CLEVECORD, a stem cell product derived from umbilical cord blood.

Read More  >